Add to ORKGMedullary thyroid carcinoma associated diarrhoea can be disabling. A 75-yr-old man with metastatic medullary thyroid carcinoma and refractory diarrhoea is described. Subcutaneous administration of the somatostatin analogue, octreotide, 100-mu-g thrice daily, resulted in a sustained improvement in diarrhoea and disappearance of faecal incontinence without reducing calcitonin levels. Octreotide therapy should be considered as symptomatic treatment for otherwise refractory diarrhoea associated with medullary thyroid carcinoma.</p
Purpose Metastatic carcinoid is an incurable malignancy whose symptoms, such as diarrhea and flushin...
Diarrhea is a prominent feature of fluorouracil (5FU) gastrointestinal toxicity, especially when 5FU...
Octreotide in the management of intestinal obstruction in terminal cancer patients
Medullary thyroid carcinoma associated diarrhoea can be disabling. A 75-yr-old man with metastatic m...
Diarrhea is a common event in the clinical history of cancer patients. It can be caused by the prese...
Chemotherapy treatment with combination of 5-fluorouracil and leucovorin or interferon alpha determi...
Cisplatin-related diarrhea is a relatively common complication in the clinical management of cancer ...
Malignant bowel obstruction and intractable diarrhea in advanced cancer are common devastating syndr...
BACKGROUND. The medical treatment of advanced medullary thyroid carcinoma (MTC) is still questionabl...
Objective: To evaluate the efficacy of octreotide in the treatment of chemoradiotherapy ( CRT)- indu...
Forty patients with chemotherapy-related diarrhea were randomized to receive (i) octreotide 0.5 mg t...
Gastrointestinal obstruction is a common problem in advanced malignant disease, but its management r...
Three patients with the carcinoid syndrome received intravenous somatostatin (3.5 micrograms/min) fo...
BACKGROUND: The medical treatment of advanced medullary thyroid carcinoma (MTC) is still questionabl...
Somatostatin analogs are promising agents in the treatment of medullary thyroid carcinoma. We have e...
Purpose Metastatic carcinoid is an incurable malignancy whose symptoms, such as diarrhea and flushin...
Diarrhea is a prominent feature of fluorouracil (5FU) gastrointestinal toxicity, especially when 5FU...
Octreotide in the management of intestinal obstruction in terminal cancer patients
Medullary thyroid carcinoma associated diarrhoea can be disabling. A 75-yr-old man with metastatic m...
Diarrhea is a common event in the clinical history of cancer patients. It can be caused by the prese...
Chemotherapy treatment with combination of 5-fluorouracil and leucovorin or interferon alpha determi...
Cisplatin-related diarrhea is a relatively common complication in the clinical management of cancer ...
Malignant bowel obstruction and intractable diarrhea in advanced cancer are common devastating syndr...
BACKGROUND. The medical treatment of advanced medullary thyroid carcinoma (MTC) is still questionabl...
Objective: To evaluate the efficacy of octreotide in the treatment of chemoradiotherapy ( CRT)- indu...
Forty patients with chemotherapy-related diarrhea were randomized to receive (i) octreotide 0.5 mg t...
Gastrointestinal obstruction is a common problem in advanced malignant disease, but its management r...
Three patients with the carcinoid syndrome received intravenous somatostatin (3.5 micrograms/min) fo...
BACKGROUND: The medical treatment of advanced medullary thyroid carcinoma (MTC) is still questionabl...
Somatostatin analogs are promising agents in the treatment of medullary thyroid carcinoma. We have e...
Purpose Metastatic carcinoid is an incurable malignancy whose symptoms, such as diarrhea and flushin...
Diarrhea is a prominent feature of fluorouracil (5FU) gastrointestinal toxicity, especially when 5FU...
Octreotide in the management of intestinal obstruction in terminal cancer patients